Entera Bio
ENTX • NASDAQ
Entera Bio is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Miranda J. Toledano, with a market cap of $51.8M.
CEOMiranda J. Toledano
Next Earnings
Upcoming earnings announcement for Entera Bio
Date
Friday, May 8, 2026 (in a month)
Timing
After Market Close (4:00 PM New York)
Fiscal Period
Q1 2026
EPS Estimate
-$0.10
Earnings History
Past 12 earnings reports for Entera Bio
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Mar 27, 2026 | Q4 2025 | -$0.06Est: -$0.09 | +33.3% | - | — |  10-K |
| Nov 14, 2025 | Q3 2025 | -$0.07Est: -$0.09 | +22.2% | - | — | 10-Q |
| Aug 8, 2025 | Q2 2025 | -$0.06Est: $1.21 | -105.0% | -Est: $163.2M | -100.0% | 10-Q |
| May 9, 2025 | Q1 2025 | -$0.06Est: -$0.07 | +14.3% | $42.0K | — | 10-Q |
| Mar 28, 2025 | Q4 2024 | -$0.06Est: -$0.08 | +25.0% | $82.0KEst: $40.0K | +105.0% | 10-K |
| Nov 8, 2024 | Q3 2024 | -$0.08Est: -$0.05 | -60.0% | $42.0KEst: $40.0K | +5.0% | 10-Q |
| Aug 9, 2024 | Q2 2024 | -$0.06Est: -$0.06 | 0.0% | $57.0K | — | 10-Q |
| May 10, 2024 | Q1 2024 | -$0.05Est: -$0.06 | +16.7% | - | — | 10-Q |
| Mar 8, 2024 | Q4 2023 | -$0.07 | — | - | — | 10-K |
| Nov 14, 2023 | Q3 2023 | -$0.08Est: -$0.09 | +11.1% | - | — | — |
| Aug 11, 2023 | Q2 2023 | -$0.08Est: -$0.07 | -14.3% | - | — | 10-Q |
| May 5, 2023 | Q1 2023 | -$0.08Est: -$0.12 | +33.3% | -Est: $100.0K | -100.0% | — |